JP2008508265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508265A5 JP2008508265A5 JP2007523501A JP2007523501A JP2008508265A5 JP 2008508265 A5 JP2008508265 A5 JP 2008508265A5 JP 2007523501 A JP2007523501 A JP 2007523501A JP 2007523501 A JP2007523501 A JP 2007523501A JP 2008508265 A5 JP2008508265 A5 JP 2008508265A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- medicament
- infection
- amino acid
- local
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077175A EP1621205A1 (en) | 2004-07-28 | 2004-07-28 | Antimicrobial peptides derived from CAP18 |
| PCT/NL2005/000545 WO2006011792A2 (en) | 2004-07-28 | 2005-07-26 | Antimicrobial peptides derived from cap18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508265A JP2008508265A (ja) | 2008-03-21 |
| JP2008508265A5 true JP2008508265A5 (https=) | 2008-09-11 |
Family
ID=34928414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007523501A Pending JP2008508265A (ja) | 2004-07-28 | 2005-07-26 | 抗菌性ペプチド |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7803756B2 (https=) |
| EP (3) | EP1621205A1 (https=) |
| JP (1) | JP2008508265A (https=) |
| KR (1) | KR20070050941A (https=) |
| CN (1) | CN101018563A (https=) |
| AU (1) | AU2005267651B2 (https=) |
| BR (1) | BRPI0513856A (https=) |
| CA (1) | CA2574959A1 (https=) |
| NZ (1) | NZ553175A (https=) |
| RU (1) | RU2392962C2 (https=) |
| WO (1) | WO2006011792A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
| JP5762683B2 (ja) | 2006-12-01 | 2015-08-12 | ラクレード，インコーポレーテッド | 耳内のバイオフィルムを溶解するための加水分解酵素及び酸化酵素の使用 |
| EP2175865A4 (en) | 2007-07-25 | 2012-01-11 | Biolex Therapeutics Inc | INTERFERON DRUG PRODUCTS WITH CONTROLLED RELEASE AND TREATMENT OF HCV INFECTIONS THEREWITH |
| US20110039763A1 (en) | 2009-01-06 | 2011-02-17 | C3 Jian, Inc. | Targeted antimicrobial moieties |
| US20130079382A1 (en) | 2009-10-12 | 2013-03-28 | Larry J. Smith | Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro |
| RU2434880C1 (ru) * | 2010-07-21 | 2011-11-27 | Общество С Ограниченной Ответственностью "Биохарт" | Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека |
| BR112014027818B1 (pt) * | 2012-05-09 | 2023-03-28 | Contrafect Corporation | Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano |
| CN105555290B (zh) * | 2013-05-10 | 2021-11-09 | 莱顿大学学术医院以Lumc的名义运作 | 抗微生物肽 |
| US9387189B2 (en) | 2013-05-22 | 2016-07-12 | Professional Compounding Centers Of America (Pcca) | Antibiotic composition comprising a chemotactic agent and a nutrient dispersion |
| WO2015075406A1 (en) * | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| PL3087092T3 (pl) | 2013-12-12 | 2018-12-31 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Peptyd przeciwdrobnoustrojowy i jego zastosowania |
| WO2015164289A1 (en) * | 2014-04-21 | 2015-10-29 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of fungal infections |
| US20250034218A1 (en) * | 2021-09-21 | 2025-01-30 | Biomedit, Llc | Antimicrobial peptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4037525B2 (ja) * | 1998-03-25 | 2008-01-23 | 生化学工業株式会社 | 新規抗菌性ペプチド |
| ATE435870T1 (de) * | 2003-01-28 | 2009-07-15 | Academisch Ziekenhuis Leiden | Aus ll-37 abgeleiteten peptidinhibitoren von toxinen |
| WO2005040192A2 (en) * | 2003-10-21 | 2005-05-06 | The Regents Of The University Of California | Human cathelicidin antimicrobial peptides |
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
-
2004
- 2004-07-28 EP EP04077175A patent/EP1621205A1/en not_active Withdrawn
-
2005
- 2005-07-26 NZ NZ553175A patent/NZ553175A/en unknown
- 2005-07-26 EP EP09158381A patent/EP2221061A1/en not_active Withdrawn
- 2005-07-26 EP EP05769152A patent/EP1784206A2/en not_active Withdrawn
- 2005-07-26 RU RU2007107390/15A patent/RU2392962C2/ru not_active IP Right Cessation
- 2005-07-26 KR KR1020077004988A patent/KR20070050941A/ko not_active Withdrawn
- 2005-07-26 AU AU2005267651A patent/AU2005267651B2/en not_active Ceased
- 2005-07-26 CN CNA2005800255122A patent/CN101018563A/zh active Pending
- 2005-07-26 JP JP2007523501A patent/JP2008508265A/ja active Pending
- 2005-07-26 US US11/658,415 patent/US7803756B2/en not_active Expired - Fee Related
- 2005-07-26 BR BRPI0513856-6A patent/BRPI0513856A/pt not_active IP Right Cessation
- 2005-07-26 CA CA002574959A patent/CA2574959A1/en not_active Abandoned
- 2005-07-26 WO PCT/NL2005/000545 patent/WO2006011792A2/en not_active Ceased
-
2010
- 2010-09-14 US US12/882,089 patent/US20110053835A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9227999B2 (en) | Antimicrobial cationic peptides and formulations thereof | |
| ES2264198T3 (es) | Composiciones y metodos para tratar infecciones utilizando peptidos cationicos a solas o en combinacion con antibioticos. | |
| US6894028B2 (en) | Use of KPV tripeptide for dermatological disorders | |
| KR101922409B1 (ko) | 화합물들 및 그 용도 | |
| JP2008508265A5 (https=) | ||
| US6780838B2 (en) | Compounds for treating fungal pathologies of the oral cavity | |
| JP2012522037A5 (https=) | ||
| Casciaro et al. | The Potential of frog skin peptides for anti-Infective therapies: the Case of Esculentin-1a (1-21) NH2 | |
| US20110053835A1 (en) | Antimicrobial peptides derived from cap18 | |
| WO2004103315A3 (en) | Treatment of ophthalmic infections using antimicrobial peptides | |
| KR20210024005A (ko) | 스태필로코커스 아우레우스 및 그람 양성 세균을 항생제에 재민감화시키기 위한 리신 및 이의 유도체 | |
| JP2010517987A (ja) | 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用 | |
| US10507227B2 (en) | Cationic antimicrobial peptides | |
| US20050074485A1 (en) | Anti-inflammatory/anti-microbial peptides for use in dialysis | |
| Walsh et al. | Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers | |
| KR101173696B1 (ko) | 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료 | |
| JP2018530622A (ja) | 尿路感染症を治療するための組成物および方法 | |
| CN109715152A (zh) | 医治感染的方法 | |
| WO2005026194A3 (en) | Granulysin peptides and methods of use thereof | |
| Gomes | Piling-Peptide-Based Ionic Liquids Towards Healing of Complicated Skin Infections | |
| JP2002161041A (ja) | 感染症治療剤 | |
| EP1758922B8 (en) | Peptide substance restoring function of respiratory organs | |
| WO2014205157A1 (en) | Inhalation composition for treating respiratory tract infections | |
| US20140377355A1 (en) | Levofloxacin Inhalation Composition | |
| Hashemi et al. | Journal of Antimicrobial Agents |